Applications from the field of Pharma & Biopharma | LabRulez ICPMS

Proposed new ICH and USP methods for elemental impurities: The application of ICP-MS and ICP-OES for pharmaceutical analysis

Technical notes

| 2014 | Agilent Technologies

ICP/MS, ICP/OES

Instrumentation

ICP/MS, ICP/OES

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

The Agilent Cary 60 UV-Vis in the Pharmaceutical Laboratory

Others

| 2015 | Agilent Technologies

UV–VIS spectrophotometry

Instrumentation

UV–VIS spectrophotometry

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

ELIMINATE VARIABILITY WITH QUALITY BY DESIGN FOR PHARMACEUTICAL DEVELOPMENT

Brochures and specifications

| 2014 | Agilent Technologies

HPLC, ICP/MS

Instrumentation

HPLC, ICP/MS

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

The determination of the palladium content in valacyclovir hydrochloride using an Agilent 720 ICP-OES according to USP 35

Applications

| 2013 | Agilent Technologies

ICP/OES

Instrumentation

ICP/OES

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

Support for Title 21 CFR Part 11 and Annex 11 Compliance: Agilent Cary UV Workstation Software for Cary 3500

Technical notes

| 2021 | Agilent Technologies

Software, UV–VIS spectrophotometry

Instrumentation

Software, UV–VIS spectrophotometry

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

Trace level analysis of sulfur, phosphorus, silicon and chlorine in NMP using the Agilent 8800 Triple Quadrupole ICP-MS

Applications

| 2013 | Agilent Technologies

ICP/MS, ICP/MS/MS

Instrumentation

ICP/MS, ICP/MS/MS

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

Support for Title 21 CFR Part 11 and Annex 11 Compliance: Agilent SpectrAA CFR software

Technical notes

| 2020 | Agilent Technologies

Software, AAS

Instrumentation

Software, AAS

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

Support for Title 21 CFR Part 11 and Annex 11 Compliance: Agilent ICP Expert 21 CFR Part 11 software

Technical notes

| 2020 | Agilent Technologies

Software, ICP/OES

Instrumentation

Software, ICP/OES

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

Support for Title 21 CFR Part 11 and Annex 11 Compliance: Agilent MicroLab Pharma

Technical notes

| 2020 | Agilent Technologies

Software, FTIR Spectroscopy

Instrumentation

Software, FTIR Spectroscopy

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

Support for Title 21 CFR Part 11 and Annex 11 Compliance: Agilent Cary WinUV Pharma

Technical notes

| 2016 | Agilent Technologies

Software, UV–VIS spectrophotometry

Instrumentation

Software, UV–VIS spectrophotometry

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

Applications from the field of Pharma & Biopharma | LabRulez ICPMS

Proposed new ICH and USP methods for elemental impurities: The application of ICP-MS and ICP-OES for pharmaceutical analysis

The Agilent Cary 60 UV-Vis in the Pharmaceutical Laboratory

ELIMINATE VARIABILITY WITH QUALITY BY DESIGN FOR PHARMACEUTICAL DEVELOPMENT

The determination of the palladium content in valacyclovir hydrochloride using an Agilent 720 ICP-OES according to USP 35

Support for Title 21 CFR Part 11 and Annex 11 Compliance: Agilent Cary UV Workstation Software for Cary 3500

Trace level analysis of sulfur, phosphorus, silicon and chlorine in NMP using the Agilent 8800 Triple Quadrupole ICP-MS

Support for Title 21 CFR Part 11 and Annex 11 Compliance: Agilent SpectrAA CFR software

Support for Title 21 CFR Part 11 and Annex 11 Compliance: Agilent ICP Expert 21 CFR Part 11 software

Support for Title 21 CFR Part 11 and Annex 11 Compliance: Agilent MicroLab Pharma

Support for Title 21 CFR Part 11 and Annex 11 Compliance: Agilent Cary WinUV Pharma

Related content

From a scientific project to a global business venture. The company mzio is striving to improve data analysis in mass spectrometry labs

Cryo-EM structures show how Trypanosomes escape the human innate immune response

An innovative approach to planar chiral substances